These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16392463)

  • 41. Interrupter technique versus plethysmography for measurement of respiratory resistance in children with asthma or cystic fibrosis.
    Oswald-Mammosser M; Charloux A; Donato L; Albrech C; Speich JP; Lampert E; Lonsdorfer J
    Pediatr Pulmonol; 2000 Mar; 29(3):213-20. PubMed ID: 10686043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V; Roberts GW; Coulthard KP; Baghurst PA; Martin A; Roberts ME; Onishko CR; Martin AJ; Linke RJ; Holmes M; Jarvinen A; Kennedy D; Colebatch KA; Hansman D; Parsons DW
    Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
    Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
    Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of pulmonary function testing during pulmonary exacerbations in cystic fibrosis.
    Rosenberg SM; Schramm CM
    Pediatr Pulmonol; 1993 Oct; 16(4):227-35. PubMed ID: 8265270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients.
    Padman R; Geouque DM; Engelhardt MT
    Del Med J; 1999 Jan; 71(1):13-8. PubMed ID: 10024754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis.
    McIlwaine PM; Wong LT; Peacock D; Davidson AG
    J Pediatr; 1997 Oct; 131(4):570-4. PubMed ID: 9386661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumothorax in cystic fibrosis: a retrospective case series.
    Hafen GM; Ukoumunne OC; Robinson PJ
    Arch Dis Child; 2006 Nov; 91(11):924-5. PubMed ID: 17056865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
    De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
    J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Objective monitoring of cough in children with cystic fibrosis.
    Hamutcu R; Francis J; Karakoc F; Bush A
    Pediatr Pulmonol; 2002 Nov; 34(5):331-5. PubMed ID: 12357476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between birth weight, maternal smoking during pregnancy and childhood and adolescent lung function: A path analysis.
    Balte P; Karmaus W; Roberts G; Kurukulaaratchy R; Mitchell F; Arshad H
    Respir Med; 2016 Dec; 121():13-20. PubMed ID: 27888986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cough versus chest physiotherapy. A comparison of the acute effects on pulmonary function in patients with cystic fibrosis.
    de Boeck C; Zinman R
    Am Rev Respir Dis; 1984 Jan; 129(1):182-4. PubMed ID: 6703478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis.
    Ranganathan SC; Bush A; Dezateux C; Carr SB; Hoo AF; Lum S; Madge S; Price J; Stroobant J; Wade A; Wallis C; Wyatt H; Stocks J
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1350-7. PubMed ID: 12421744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.
    Colombo C; Faelli N; Tirelli AS; Fortunato F; Biffi A; Claut L; Cariani L; Daccò V; Prato R; Conese M
    Int J Immunopathol Pharmacol; 2011; 24(2):423-32. PubMed ID: 21658316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis.
    Mortensen J; Falk M; Groth S; Jensen C
    Chest; 1991 Nov; 100(5):1350-7. PubMed ID: 1935294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The immediate effects of a single autogenic drainage session on ventilatory mechanics in adult subjects with cystic fibrosis.
    Wallaert E; Perez T; Prevotat A; Reychler G; Wallaert B; Le Rouzic O
    PLoS One; 2018; 13(3):e0195154. PubMed ID: 29596479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.
    Schechter MS; VanDevanter DR; Pasta DJ; Short SA; Morgan WJ; Konstan MW;
    Ann Am Thorac Soc; 2018 Feb; 15(2):225-233. PubMed ID: 29140726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.